[NEW YORK] Pfizer agreed Monday to combine its off-patent drugs division, which controls treatments like the statin Lipitor, with the pharmaceutical company Mylan, creating a potential powerhouse...

[NEW YORK] US pharmaceutical giant Pfizer on Monday announced the acquisition of Array BioPharma, a biotechnology firm that specializes in cancer drugs, the latest in a long list of biotech...

[BENGALURU] Pfizer Inc said on Wednesday it acquired a 15 per cent stake in Vivet Therapeutics, as well as an exclusive option to fully acquire it, a deal that will give it access to the French...

[NEW YORK] Wall Street stocks fell Wednesday, continuing its run of recent weakness amid a dimming global economic outlook.

[LONDON] Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines to create a new business with...

PFIZER Inc said on Friday that it plans to hike US prices on 41 of its medicines in January, after walking back its previous planned price increases this summer under pressure from President...

[LONDON] European companies aren't alone in their Brexit pain. Pfizer Inc., the US-based drug behemoth, says its costs for dealing with the upcoming split will reach US$100 million.

PFIZER INC said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 per cent, boosting the prospects of what could be a...